Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
10
3
4
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (10)
Patient-Centered Assessment of Symptoms and Outcomes
Chronic Infections and Inflammation in ME/CFS: An Observational Study
Low-Dose Naltrexone For ME/CFS: Dose-Finding
The Effect of Acupuncture Therapy on Cognitive Function in Post-COVID-19 Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Application of Direct Current Transcranial stImulation, Remotely superVised in Chronic fATiguE
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
RCT of Mind-body in Long COVID and Myalgic Encephalomyelitis
Bright Light Therapy in ME/CFS Patients
Hydrogen Water Dosing Study for ME/CFS
The Exercise Response to Pharmacologic Cholinergic Stimulation in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome